Assetmark, Inc Nevro Corp Transaction History

Assetmark, Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$13.56 - $20.78 $3,729 - $5,714	-275 Reduced 8.78%	2,856 $41,000
Q4 2023 Feb 09, 2024	BUY	$14.18 - $22.31 $10,351 - $16,286	730 Added 30.4%	3,131 $67,000
Q3 2023 Oct 27, 2023	BUY	$18.22 - $25.85 $2,969 - $4,213	163 Added 7.28%	2,401 $46,000
Q2 2023 Aug 11, 2023	BUY	$22.62 - $39.32 $13,888 - $24,142	614 Added 37.81%	2,238 $56,000
Q1 2023 May 05, 2023	BUY	$30.17 - $41.11 $14,662 - $19,979	486 Added 42.71%	1,624 $58,000
Q4 2022 Feb 10, 2023	BUY	$36.43 - $49.4 $7,577 - $10,275	208 Added 22.37%	1,138 $45,000
Q3 2022 Nov 01, 2022	BUY	$40.66 - $53.03 $14,678 - $19,143	361 Added 63.44%	930 $43,000
Q2 2022 Aug 03, 2022	BUY	$40.85 - $77.67 $13,480 - $25,631	330 Added 138.08%	569 $25,000
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $14,328 - $22,002	239 New	239 $17,000
Q4 2019 Feb 11, 2020	SELL	$76.41 - $117.54 $916 - $1,410	-12 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$69.46 - $88.57 $347 - $442	-5 Reduced 29.41%	12 $1,000
Q4 2017 Feb 13, 2018	BUY	$65.94 - $93.31 $329 - $466	5 Added 41.67%	17 $1,000
Q2 2017 Aug 15, 2017	BUY	N/A	12	12 $1,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.